daunorubicin has been researched along with Anasarca in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fahr, A; Fariya, MK; Nagarsenker, MS; Rajawat, GS; Steiniger, F; Varghese, SE | 1 |
Conte, ML; Indolfi, P; La Manna, A; Locatelli, F; Nobili, B; Perrotta, S; Rossi, F | 1 |
Ben-Am, M; Burnett, A; Capdeville, R; Dekker, A; Ferrant, C; Gratwohl, A; Kovacsovics, T; Löwenberg, B; Ossenkoppele, G; Pfister, C; Rosenkranz, G; Sonneveld, P; Vellenga, E; Verhoef, G; Vossebeld, P; Yin, L | 1 |
Ellis, W; Little, HL | 1 |
Gaeta, JF; Halazun, JF; Sinks, LF; Wagner, HR | 1 |
Bateman, CJ; Crowther, D; Fairley, GH; Malpas, JS; Scott, RB; Vartan, CP; Whitehouse, JM | 1 |
2 trial(s) available for daunorubicin and Anasarca
Article | Year |
---|---|
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cohort Studies; Cyclosporins; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Edema; Female; Fever; Humans; Hypokalemia; Leukemia, Myeloid; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasm Proteins; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome | 2000 |
Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
Topics: Adolescent; Adult; Aged; Asparaginase; Blood Cell Count; Clinical Trials as Topic; Cytarabine; Daunorubicin; Edema; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Serum Albumin; Vomiting | 1970 |
4 other study(ies) available for daunorubicin and Anasarca
Article | Year |
---|---|
Lecithin and PLGA-based self-assembled nanocomposite, Lecithmer: preparation, characterization, and pharmacokinetic/pharmacodynamic evaluation.
Topics: Animals; Cell Survival; Cells, Cultured; Daunorubicin; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Edema; Humans; Lactic Acid; Lecithins; Male; Nanocomposites; Piroxicam; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats | 2016 |
Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Edema; Glomerulonephritis, Membranous; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2005 |
Leukemic infiltration of the optic nerve head.
Topics: Busulfan; Child; Daunorubicin; Edema; Female; Humans; Intracranial Pressure; Leukemia, Myeloid; Methotrexate; Optic Nerve; Papilledema; Pulmonary Embolism | 1973 |
Proceedings: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia.
Topics: Adolescent; Age Factors; Autopsy; Child; Child, Preschool; Daunorubicin; Drug Therapy, Combination; Edema; Electrocardiography; Female; Heart; Heart Conduction System; Heart Failure; Humans; Leukemia, Lymphoid; Male; Methotrexate; Myocardium; Myofibrils; Prednisone; Remission, Spontaneous; Vincristine | 1974 |